Aethlon Medical Inc
AEMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$664.75K
Close$
$3.11
337.7% upside
Current Fair Value
337.7% upsideUndervalued by 337.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $664,751.00 |
|---|---|
| Enterprise Value | $-4,024,989.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-10.61 |
| Beta | 1.32 |
| Outstanding Shares | 1,570,449 |
Return
| Return on Equity | -107834.51% |
|---|---|
| Return on Assets | -83199.09% |
| Return on Invested Capital | -30473.73% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | 0.08 |
| Price to Sales | - |
| Price to Book Ratio | 0.24 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 25, 2026
EPS Estimate
$-2.17
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.79
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.60%▲ 6.60% |
|---|---|
| Total Invested | $155,016▲ 239.63% |
| Investors Holding | 12▲ 4.00% |
ESG Score
No data
About Aethlon Medical Inc
CEO: Timothy Rodell